Thrivent Financial For Lutherans Pacira Bio Sciences, Inc. Transaction History

Thrivent Financial For Lutherans

$45.7 Billion
Q2 2025

A detailed history of Thrivent Financial For Lutherans transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Thrivent Financial For Lutherans holds 34,049 shares of PCRX stock, worth $757,930. This represents 0.0% of its overall portfolio holdings.

Number of Shares

34,049

Previous 33,915 0.4%

Holding current value

$757,930

Previous $843,000 3.44%

% of portfolio

0.0%

Previous 0.0%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2025 Aug 26, 2025	BUY	$22.91 - $27.14 $3,069 - $3,636	134 Added 0.4%	34,049 $814,000
Q1 2025 Aug 26, 2025	BUY	$18.33 - $27.25 $621,661 - $924,183	33,915 New	33,915 $843,000
Q4 2024 Feb 10, 2025	SELL	$15.3 - $20.33 $8,170 - $10,856	-534 Reduced 1.47%	35,689 $672,000
Q3 2024 Nov 07, 2024	SELL	$11.7 - $28.46 $28,278 - $68,787	-2,417 Reduced 6.26%	36,223 $545,000
Q2 2024 Aug 13, 2024	SELL	$25.5 - $31.51 $719,712 - $889,338	-28,224 Reduced 42.21%	38,640 $1.11 Million
Q1 2024 May 14, 2024	SELL	$27.7 - $35.48 $306,001 - $391,947	-11,047 Reduced 14.18%	66,864 $1.95 Million
Q4 2023 Feb 14, 2024	SELL	$26.32 - $34.31 $364,453 - $475,090	-13,847 Reduced 15.09%	77,911 $2.63 Million
Q3 2023 Nov 14, 2023	BUY	$30.68 - $40.09 $1.47 Million - $1.91 Million	47,764 Added 108.57%	91,758 $2.82 Million
Q2 2023 Aug 14, 2023	SELL	$36.12 - $47.5 $53,313 - $70,110	-1,476 Reduced 3.25%	43,994 $1.76 Million
Q1 2023 May 17, 2023	SELL	$35.53 - $43.38 $56,599 - $69,104	-1,593 Reduced 3.38%	45,470 $1.86 Million
Q4 2022 Feb 08, 2023	SELL	$38.19 - $57.45 $11,686 - $17,579	-306 Reduced 0.65%	47,063 $1.82 Million
Q3 2022 Nov 14, 2022	BUY	$51.24 - $58.89 $139,885 - $160,769	2,730 Added 6.12%	47,369 $2.52 Million
Q2 2022 Aug 16, 2022	BUY	$51.49 - $81.64 $431,331 - $683,898	8,377 Added 23.1%	44,639 $2.6 Million
Q1 2022 May 13, 2022	BUY	$60.03 - $76.49 $720 - $917	12 Added 0.03%	36,262 $2.77 Million
Q4 2021 Feb 16, 2022	BUY	$47.97 - $62.21 $15,206 - $19,720	317 Added 0.88%	36,250 $2.18 Million
Q3 2021 Nov 15, 2021	SELL	$54.64 - $61.3 $3,114 - $3,494	-57 Reduced 0.16%	35,933 $2.01 Million
Q2 2021 Aug 19, 2021	SELL	$59.18 - $69.99 $2,485 - $2,939	-42 Reduced 0.12%	35,990 $2.18 Million
Q1 2021 May 17, 2021	BUY	$59.31 - $78.82 $4,270 - $5,675	72 Added 0.2%	36,032 $2.53 Million
Q4 2020 Feb 16, 2021	BUY	$50.47 - $66.26 $26,193 - $34,388	519 Added 1.46%	35,960 $2.15 Million
Q3 2020 Nov 10, 2020	BUY	$51.97 - $63.0 $9,614 - $11,655	185 Added 0.52%	35,441 $2.13 Million
Q2 2020 Aug 12, 2020	BUY	$30.8 - $52.47 $8,685 - $14,796	282 Added 0.81%	35,256 $1.85 Million
Q1 2020 May 15, 2020	BUY	$28.4 - $50.7 $49,586 - $88,522	1,746 Added 5.25%	34,974 $1.17 Million
Q4 2019 Feb 13, 2020	BUY	$36.31 - $46.83 $8,206 - $10,583	226 Added 0.68%	33,228 $1.51 Million
Q3 2019 Nov 14, 2019	BUY	$35.66 - $44.99 $1.18 Million - $1.48 Million	33,002 New	33,002 $1.26 Million

Others Institutions Holding PCRX

# of Institutions

259

Shares Held

51.2M

Call Options Held

289K

Put Options Held

130K

View Full List

About Pacira BioSciences, Inc.

Ticker PCRX
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 45,824,200
Market Cap $1.02B
Description
Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...

More about PCRX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Thrivent Financial For Lutherans, based on Form 13F filings with the SEC.

News

Stay updated on Thrivent Financial For Lutherans with notifications on news.

Account

Thrivent Financial For Lutherans Pacira Bio Sciences, Inc. Transaction History